Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Regulus_Therapeutics> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- Regulus_Therapeutics abstract "Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a biopharmaceutical company focused on the development of microRNA-based drugs targeting fibrosis, metabolism and cardiovascular diseases, cancer, HCV and immune-related diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.".
- Regulus_Therapeutics foundingYear "2007".
- Regulus_Therapeutics industry Biotechnology.
- Regulus_Therapeutics location San_Diego.
- Regulus_Therapeutics numberOfEmployees "54".
- Regulus_Therapeutics product MicroRNA_therapeutics.
- Regulus_Therapeutics wikiPageExternalLink www.regulusrx.com.
- Regulus_Therapeutics wikiPageExternalLink www.regulusrx.com.
- Regulus_Therapeutics wikiPageID "32446059".
- Regulus_Therapeutics wikiPageRevisionID "600897959".
- Regulus_Therapeutics foundation "September 2007".
- Regulus_Therapeutics hasPhotoCollection Regulus_Therapeutics.
- Regulus_Therapeutics homepage www.regulusrx.com.
- Regulus_Therapeutics industry Biotechnology.
- Regulus_Therapeutics keyPeople "Kleanthis G. Xanthopoulos, Ph.D.".
- Regulus_Therapeutics keyPeople "Neil W. Gibson, Ph.D.".
- Regulus_Therapeutics location "San Diego, California, USA".
- Regulus_Therapeutics name "Regulus Therapeutics Inc.".
- Regulus_Therapeutics numEmployees "54".
- Regulus_Therapeutics products MicroRNA_therapeutics.
- Regulus_Therapeutics type "Public".
- Regulus_Therapeutics subject Category:Pharmaceutical_companies_of_the_United_States.
- Regulus_Therapeutics type Abstraction100002137.
- Regulus_Therapeutics type Company108058098.
- Regulus_Therapeutics type DrugCompany108002578.
- Regulus_Therapeutics type Group100031264.
- Regulus_Therapeutics type Institution108053576.
- Regulus_Therapeutics type Organization108008335.
- Regulus_Therapeutics type PharmaceuticalCompaniesOfTheUnitedStates.
- Regulus_Therapeutics type SocialGroup107950920.
- Regulus_Therapeutics type YagoLegalActor.
- Regulus_Therapeutics type YagoLegalActorGeo.
- Regulus_Therapeutics type YagoPermanentlyLocatedEntity.
- Regulus_Therapeutics type Agent.
- Regulus_Therapeutics type Company.
- Regulus_Therapeutics type Organisation.
- Regulus_Therapeutics type Organization.
- Regulus_Therapeutics type Agent.
- Regulus_Therapeutics type SocialPerson.
- Regulus_Therapeutics type Thing.
- Regulus_Therapeutics comment "Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a biopharmaceutical company focused on the development of microRNA-based drugs targeting fibrosis, metabolism and cardiovascular diseases, cancer, HCV and immune-related diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.".
- Regulus_Therapeutics label "Regulus Therapeutics".
- Regulus_Therapeutics sameAs m.05c6wzw.
- Regulus_Therapeutics sameAs Q7309716.
- Regulus_Therapeutics sameAs Q7309716.
- Regulus_Therapeutics sameAs Regulus_Therapeutics.
- Regulus_Therapeutics wasDerivedFrom Regulus_Therapeutics?oldid=600897959.
- Regulus_Therapeutics homepage www.regulusrx.com.
- Regulus_Therapeutics isPrimaryTopicOf Regulus_Therapeutics.
- Regulus_Therapeutics name "Regulus Therapeutics Inc.".